ARCHIVES

FDA Grants Six-Month Priority Review To Nolvadex For DCIS Adjuvant Treatment.

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

Draft Report Outlines New Toxicological Test Criteria

November 24, 1995

UT Health System’s Probe Finds Lapses at MD Anderson, CPRIT—But No Nepotism

June 15, 2012

Two Drugs Slow Progress Of Metastatic Prostate Cancer

June 29, 2001

Receipt Dates Clarified For AIDS-Cancers PA

July 4, 1997

In Senate testimony, NCI director uses survival rate as measure of progress for goal to “eliminate suffering and death due to cancer.”

July 29, 2005

Huebner Retires, Named Scientist Emeritus

November 19, 1982